All eyes on NICE (UK National Institute for Clinical Excellence) for medtech innovation news:
This article was originally published in Clinica
Executive Summary
As Clinica went to press, the UK's National Institute for Clinical Excellence (NICE) annual public meeting was debating a full programme, including the approval of the new process guide of the Interventional Procedures Programme. This programme to appraise new or rare diagnostic and therapeutic technologies (the revamped SERNIP) is close to the heart of the UK medical technology industry's campaign for greater market access to new devices.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.